TY  - GEN
AU  - Stieglitz,Elliot
AU  - Ward,Ashley F
AU  - Gerbing,Robert B
AU  - Alonzo,Todd A
AU  - Arceci,Robert J
AU  - Liu,Y Lucy
AU  - Emanuel,Peter D
AU  - Widemann,Brigitte C
AU  - Cheng,Jennifer W
AU  - Jayaprakash,Nalini
AU  - Balis,Frank M
AU  - Castleberry,Robert P
AU  - Bunin,Nancy J
AU  - Loh,Mignon L
AU  - Cooper,Todd M
TI  - Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group
SN  - 1545-5017
PY  - 2015///0611
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Child
KW  - Child, Preschool
KW  - Cytarabine
KW  - Disease-Free Survival
KW  - Enzyme Inhibitors
KW  - Farnesyl-Diphosphate Farnesyltransferase
KW  - antagonists & inhibitors
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Infant
KW  - Isotretinoin
KW  - Leukemia, Myelomonocytic, Juvenile
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Quinolones
KW  - Survival Rate
KW  - Vidarabine
N1  - Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study
UR  - https://doi.org/10.1002/pbc.25342
ER  -